Progress in therapeutic targets on podocyte for Alport syndrome.

作者信息

Zheng Qimin, Gu Xiangchen, He John Cijiang, Xie Jingyuan

机构信息

Department of Nephrology, Shanghai Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.

Institute of Nephrology, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.

出版信息

J Transl Int Med. 2024 May 21;12(2):129-133. doi: 10.2478/jtim-2024-0005. eCollection 2024 Apr.

DOI:10.2478/jtim-2024-0005

PMID:38812923

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11135632/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f1a/11135632/f34c144a4595/j_jtim-2024-0005_fig_001.jpg

相似文献

[1]

Progress in therapeutic targets on podocyte for Alport syndrome.

J Transl Int Med. 2024-5-21

[2]

Accelerated podocyte detachment and progressive podocyte loss from glomeruli with age in Alport Syndrome.

Kidney Int. 2017-7-26

[3]

Patient-derived podocyte spheroids reveal new insights into the etiopathogenesis of Alport syndrome.

Front Cell Dev Biol. 2023-3-2

[4]

Tumour necrosis factor-α drives Alport glomerulosclerosis in mice by promoting podocyte apoptosis.

J Pathol. 2011-9-26

[5]

Induced Pluripotent Stem Cell-Derived Podocyte-Like Cells as Models for Assessing Mechanisms Underlying Heritable Disease Phenotype: Initial Studies Using Two Alport Syndrome Patient Lines Indicate Impaired Potassium Channel Activity.

J Pharmacol Exp Ther. 2018-8-13

[6]

Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome.

Clin J Am Soc Nephrol. 2016-8-8

[7]

A Neutralizing IL-11 Antibody Improves Renal Function and Increases Lifespan in a Mouse Model of Alport Syndrome.

J Am Soc Nephrol. 2022-4

[8]

Synaptopodin deficiency exacerbates kidney disease in a mouse model of Alport syndrome.

Am J Physiol Renal Physiol. 2021-7-1

[9]

Advances and unmet needs in genetic, basic and clinical science in Alport syndrome: report from the 2015 International Workshop on Alport Syndrome.

Nephrol Dial Transplant. 2017-6-1

[10]

Podocyte Depletion in Thin GBM and Alport Syndrome.

PLoS One. 2016-5-18

引用本文的文献

[1]

IRE1α modulates M1 oncolytic virus sensitivity via ER stress regulation in bladder cancer.

Cancer Drug Resist. 2025-8-13

[2]

A comprehensive splicing characterization of COL4A5 mutations and prognostic significance in a single cohort with X-linked alport syndrome.

Front Genet. 2025-6-11

本文引用的文献

[1]

COL4A3 Mutation Induced Podocyte Apoptosis by Dysregulation of NADPH Oxidase 4 and MMP-2.

Kidney Int Rep. 2023-6-19

[2]

Finerenone Added to RAS/SGLT2 Blockade for CKD in Alport Syndrome. Results of a Randomized Controlled Trial with Col4a3-/- Mice.

J Am Soc Nephrol. 2023-9-1

[3]

Serum myoglobin modulates kidney injury via inducing ferroptosis after exertional heatstroke.

J Transl Int Med. 2023-7-5

[4]

Empagliflozin reduces podocyte lipotoxicity in experimental Alport syndrome.

Elife. 2023-5-2

[5]

Effects of Bardoxolone Methyl in Alport Syndrome.

Clin J Am Soc Nephrol. 2022-12

[6]

Nrf2 Activation in Chronic Kidney Disease: Promises and Pitfalls.

Antioxidants (Basel). 2022-6-3

[7]

NanoLuc reporters identify nonsense mutations susceptible to drug-induced stop codon readthrough.

iScience. 2022-2-8

[8]

Effect of disease progression on the podocyte cell cycle in Alport Syndrome.

Kidney Int. 2022-1

[9]

Prevalence Estimates of Predicted Pathogenic Variants in a Population Sequencing Database and Their Implications for Alport Syndrome.

J Am Soc Nephrol. 2021-9

[10]

Compounds targeting OSBPL7 increase ABCA1-dependent cholesterol efflux preserving kidney function in two models of kidney disease.

Nat Commun. 2021-8-2

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Progress in therapeutic targets on podocyte for Alport syndrome.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献